# A 48 Week Study to Evaluate the Efficacy and Safety of Two (2) EYS606 Treatment Regimens in Subjects With Active Chronic Non-infectious Uveitis (CNIU)

> **NCT04207983** · PHASE2 · COMPLETED · sponsor: **Eyevensys** · enrollment: 3 (actual)

## Conditions studied

- Non-infectious Uveitis

## Interventions

- **COMBINATION_PRODUCT:** EYS606

## Key facts

- **NCT ID:** NCT04207983
- **Lead sponsor:** Eyevensys
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-03
- **Primary completion:** 2021-10-05
- **Final completion:** 2021-10-05
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2022-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04207983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04207983, "A 48 Week Study to Evaluate the Efficacy and Safety of Two (2) EYS606 Treatment Regimens in Subjects With Active Chronic Non-infectious Uveitis (CNIU)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04207983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*